Skip to main content

Form 4 Insider Transactions

Updated Jun 24, 2026 at 8:22pm

Research Draft Medium 1,207 words

Form 4 is the SEC filing through which corporate "insiders" — officers, directors, and beneficial owners of more than 10% of a class of equity — disclose nearly every change in their ownership of company securities, due within two business days of the transaction. As a signal it carries a built-in tension: insiders are the best-informed buyers and sellers of their own stock and trade their own money, yet most of their reported activity is mechanical (option grants, vesting, scheduled selling) and tells you nothing. The analytical work is separating the rare opportunistic signal from the dominant routine noise.

How it's formed (the filing mechanics)

Form 4 exists under Section 16(a) of the Securities Exchange Act of 1934. Three categories must file: officers, directors, and >10% beneficial owners. The reporting chain runs Form 3 (initial holdings, within 10 days of becoming an insider), Form 4 (changes, within two business days), and Form 5 (an annual catch-up for small/exempt items, within 45 days of fiscal year-end). All are filed to EDGAR and are public immediately. The two-day deadline is hard — a third-day filing is "late" regardless of reason, and late filings must be disclosed in the issuer's proxy/10-K (per Winston & Strawn / DFIN).

The form has two tables. Table I is non-derivative securities (common stock); Table II is derivatives (options, warrants, convertibles, RSUs). Each row carries a single-letter transaction code that is the heart of interpretation (per the SEC code list, secdatabase, stocktitan):

  • P — open-market or direct purchase (the most informative bullish code)
  • S — open-market or direct sale
  • A — grant/award from the company (compensation, not a market view)
  • M — exercise of a derivative; F — shares withheld for taxes; G — gift
  • V — transaction the filer voluntarily reports early
  • A separate checkbox (mandatory on Forms 4/5 filed on or after April 1, 2023) flags whether the trade was made under a Rule 10b5-1 plan

Codes M, F, A are almost always compensation plumbing — an executive exercising vested options and selling to cover taxes generates S and F rows that look like "selling" but reflect zero conviction. The footnotes matter as much as the rows: they disclose 10b5-1 plan adoption dates, vesting terms, gift recipients, and indirect-ownership structures (trusts, LLCs, spouse holdings).

How it's used in practice

Practitioners treat Form 4 as an asymmetric signal, and the central rule is: purchases inform, sales rarely do. A discretionary open-market P is a genuine vote — the insider chose to commit personal after-tax cash. Sales (S) have many innocent drivers (diversification, taxes, tuition, divorce, a new house), so they carry far less information.

Standard refinements before treating a buy as a signal:

  • Strip the noise. Ignore A/M/F/G rows; focus on open-market P (and discretionary S).
  • Size relative to the insider. A purchase that meaningfully increases the insider's holdings or represents a large dollar commitment relative to their compensation matters more than a token buy.
  • Who bought. A CEO or CFO buy is generally read as more informed than an independent director's.
  • Cluster buying. Several insiders buying independently in a short window is the strongest configuration — multi-person confirmation, not one person's idiosyncratic reason.
  • Routine vs opportunistic. Buys that break an insider's habitual calendar pattern are the informative ones; trades flagged as 10b5-1 (the checkbox) are pre-scheduled and should be discounted.
  • Context. A buy during a drawdown or right after an earnings reset reads differently than one at all-time highs.

Adoption, debate & evidence

Insider-purchase data is widely tracked (specialist services, financial portals, and the academic literature), and the purchase-side evidence is among the more credible "footprint" signals in markets — with important caveats.

  • Jeng, Metrick & Zeckhauser (2003) report the insider-purchase portfolio earned abnormal returns of about 40 basis points per month (the authors characterize this as roughly 6% per year on an annualized basis), while the insider sale portfolio earned no significant abnormal returns — the canonical asymmetry.
  • Lakonishok & Lee (2001), studying 1975–1995, find purchases predict positive 12-month abnormal returns, concentrated in smaller-cap firms where the insider information edge is largest.
  • Cohen, Malloy & Pomorski (2012, Journal of Finance) show the edge lives almost entirely in "opportunistic" trades (irregular timing); their routine (calendar-predictable) trades produced essentially no abnormal return, while a strategy concentrated in opportunistic trades earned value-weighted abnormal returns of about 82 basis points per month in their sample.

The honest qualifications: results are strongest in small/micro caps (precisely where liquidity and capacity are worst), much of the cited research predates the modern two-day deadline and 2023 disclosure regime, and effect sizes vary by sample and method. Public availability also means any edge is partly arbitraged away once a filing hits EDGAR; the signal is real but smaller and slower than headlines suggest, and not a standalone strategy. Treat any single precise figure as sample-specific, not a forward guarantee.

Strengths & limitations

Strengths. Legally mandated, near-real-time, free, hard to fake (filing falsely is a securities offense), and grounded in the best-informed agents trading their own capital. The purchase asymmetry is one of the better-documented anomalies.

Limitations. Sales are mostly uninformative — the #1 misuse is reading every S as bearish, when option-exercise/tax (M/F) and 10b5-1 selling dominate the count. Other failure modes: 10b5-1 buys are pre-committed (no current view), small "optics" buys can be signaling theater, the edge concentrates in illiquid names, the two-day lag plus public dissemination erodes timeliness, and insiders can simply be wrong — they are biased optimists about their own firm. A late or amended filing can also distort the timeline.

Sources

Disputes flagged: exact abnormal-return figures are sample-specific and vary across studies; effects are strongest in small/micro caps and partly predate the modern filing/disclosure regime — the purchase signal is real but more modest and slower than popular sources imply.